GlassScriptPhysician profile
Sana Muneer
NPI 1801049705
$1,974.87
in general payments reported to CMS, 2019-2025
34 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.89 · 2020: $300 · 2021: $506 · 2022: $410 · 2023: $172 · 2024: $372 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $218.94 | 2021-2025 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $211.82 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $187.37 | 2020-2025 | Lokelma |
| Lilly USA, LLC | $182.98 | 2020-2022 | |
| Insulet Corporation | $104.00 | 2023-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $103.70 | 2019-2023 | |
| Inspire Medical Systems, INC. | $99.24 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.74 | 2021-2024 | Ofev |
| Pfizer INC. | $81.97 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $79.74 | 2020-2025 | Capvaxive, Gardasil 9 |
| Amgen INC. | $71.07 | 2020-2022 | |
| Corcept Therapeutics | $58.75 | 2022-2024 | Korlym |
| Exact Sciences Corporation | $41.12 | 2024-2025 | Cologuard Collection Kit |
| Ascensia Diabetes Care US INC. | $40.29 | 2024 | |
| Xeris Pharmaceuticals, INC. | $36.80 | 2022-2023 | Gvoke Hypopen |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $34.42 | 2022 | |
| Cequr Corporation | $34.08 | 2023-2024 | Cequr Simplicity |
| Axsome Therapeutics, INC. | $31.01 | 2025 | Symbravo |
| Arbor Pharmaceuticals, INC. | $24.59 | 2021 | |
| Medtronic, INC. | $20.00 | 2024 | Minimed 780g |
| Abbott Laboratories | $18.84 | 2024 | Freestyle Libre 3 |
| Alexion Pharmaceuticals, INC. | $18.13 | 2022 | |
| Jazz Pharmaceuticals INC. | $18.08 | 2022 | |
| Upsher-Smith Laboratories LLC | $17.97 | 2022 | |
| Tandem Diabetes Care, INC. | $17.55 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amneal Pharmaceuticals LLC | $17.47 | 2023 | Unithroid |
| Shire North American Group INC | $16.39 | 2019 | |
| Mannkind Corporation | $15.99 | 2022 | |
| Glaxosmithkline, LLC. | $15.91 | 2022 | |
| Acerus Pharmaceuticals Corporation | $15.51 | 2021 | |
| Antares Pharma, INC. | $15.03 | 2021 | |
| Recordati_rare_diseases_inc. | $14.52 | 2024 | Isturisa, Signifor Lar |
| Eisai INC. | $12.82 | 2019 | |
| Amarin Pharma, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Muneer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.